Drugs / IPX054
last change Dec 2007 re-read 2 minutes ago

IPX054

Developed for
Parkinson disease
Investigated by
Impax Laboratories, LLC

Trials 1 · a red edge is where a trial was stopped

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00279825 Jan 2006 → Dec 2007 Parkinson disease Impax Laboratories, LLC Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IPX054 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00279825